Opposing roles of STAT-1 and STAT-3 in regulating vascular endothelial growth factor expression in vascular smooth muscle cells

Biochemical and Biophysical Research Communications

Volumn 428, Issue 1, 2012, Pages 179-184

  Albasanz Puig, Adaia ^a   Murray, Jacqueline ^a   Namekata, Mayumi ^a   Wijelath, Errol S ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

HIF 1 ; Oncostatin M; Smooth muscle cell; STAT 1; STAT 3; VEGF

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; ONCOSTATIN M; STAT1 PROTEIN; STAT3 PROTEIN; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR SMOOTH MUSCLE;

CELLS, CULTURED; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; ONCOSTATIN M; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84868340664     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.037     Document Type: Article

References (45)

1. Flamme I., Frolich T., Risau W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J. Cell Physiol. 1997, 173:206-210.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1995, 1:27-31.
3. Moulton K.S., Heller E., Konerding M.A., Flynn E., Palinski W., Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 1999, 99:1726-1732.
4. Moulton K.S., Vakili K., Zurakowski D., Soliman M., Butterfield C., Sylvin E., Lo K.M., Gillies S., Javaherian K., Folkman J. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc. Natl. Acad. Sci. USA 2003, 100:4736-4741.
5. Jeziorska M., Woolley D.E. Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries. J. Pathol. 1999, 188:189-196.
6. McCarthy M.J., Loftus I.M., Thompson M.M., Jones L., London N.J., Bell P.R., Naylor A.R., Brindle N.P. Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J. Vasc. Surg. 1999, 30:261-268.
7. Dunmore B.J., McCarthy M.J., Naylor A.R., Brindle N.P. Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques. J. Vasc. Surg. 2007, 45:155-159.
8. Virmani R., Kolodgie F.D., Burke A.P., Finn A.V., Gold H.K., Tulenko T.N., Wrenn S.P., Narula J. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2054-2061.
9. albasanz-Puig A., Murray J., Preusch M., Coan D., Namekata M., Patel Y., Dong Z.M., Rosenfeld M.E., Wijelath E.S. Oncostatin M is expressed in atherosclerotic lesions: a role for Oncostatin M in the pathogenesis of atherosclerosis. Atherosclerosis 2011, 216:292-298.
10. Demyanets S., Huber K., Wojta J. Vascular effects of glycoprotein130 ligands - part I: pathophysiological role. Vascul. Pharmacol. 2012, 56:34-46.
11. Demyanets S., Kaun C., Rychli K., Pfaffenberger S., Kastl S.P., Hohensinner P.J., Rega G., Katsaros K.M., Afonyushkin T., Bochkov V.N., Paireder M., Huk I., Maurer G., Huber K., Wojta J. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-gamma. Basic Res. Cardiol. 2011, 106:217-231.
12. Bazan J.F. Neuropoietic cytokines in the hematopoietic fold. Neuron 1991, 7:197-208.
13. Rose T.M., Bruce A.G. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. Proc. Natl. Acad. Sci. USA 1991, 88:8641-8645.
14. Darnell J.E. STATs and gene regulation. Science 1997, 277:1630-1635.
15. Schindler C., Levy D.E., Decker T. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 2007, 282:20059-20063.
16. Nishibe T., Parry G., Ishida A., Aziz S., Murray J., Patel Y., Rahman S., Strand K., Saito K., Saito Y., Hammond W.P., Savidge G.F., Mackman N., Wijelath E.S. Oncostatin M promotes biphasic tissue factor expression in smooth muscle cells: evidence for Erk-1/2 activation. Blood 2001, 97:692-699.
17. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
18. Seidel H.M., Lamb P., Rosen J. Pharmaceutical intervention in the JAK/STAT signaling pathway. Oncogene 2000, 19:2645-2656.
19. Zhou J., Brune B. Cytokines and hormones in the regulation of hypoxia inducible factor-1alpha (HIF-1alpha). Cardiovasc. Hematol. Agents Med. Chem. 2006, 4:189-197.
20. Xu Q., Briggs J., Park S., Niu G., Kortylewski M., Zhang S., Gritsko T., Turkson J., Kay H., Semenza G.L., Cheng J.Q., Jove R., Yu H. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 2005, 24:5552-5560.
21. Page E.L., Robitaille G.A., Pouyssegur J., Richard D.E. Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J. Biol. Chem. 2002, 277:48403-48409.
22. Fukuda R., Hirota K., Fan F., Jung Y.D., Ellis L.M., Semenza G.L. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 2002, 277:38205-38211.
23. Jung J.E., Lee H.G., Cho I.H., Chung D.H., Yoon S.H., Yang Y.M., Lee J.W., Choi S., Park J.W., Ye S.K., Chung M.H. STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J. 2005, 19:1296-1298.
24. Fossey S.L., Bear M.D., Kisseberth W.C., Pennell M., London C.A. Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines. BMC Cancer 2011, 11:125.
25. Repovic P., Fears C.Y., Gladson C.L., Benveniste E.N. Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells. Oncogene 2003, 22:8117-8124.
26. Vollmer S., Kappler V., Kaczor J., Flugel D., Rolvering C., Kato N., Kietzmann T., Behrmann I., Haan C. Hypoxia-inducible factor 1alpha is up-regulated by oncostatin M and participates in oncostatin M signaling. Hepatology 2009, 50:253-260.
27. Moreno P.R., Purushothaman K.R., Fuster V., Echeverri D., Truszczynska H., Sharma S.K., Badimon J.J., O'Connor W.N. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 2004, 110:2032-2038.
28. Russell D.A., Abbott C.R., Gough M.J. Vascular endothelial growth factor is associated with histological instability of carotid plaques. Br. J. Surg. 2008, 95:576-581.
29. Cohen T., Nahari D., Cerem L.W., Neufeld G., Levi B.Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 1996, 271:736-741.
30. Vasse M., Pourtau J., Trochon V., Muraine M., Vannier J.P., Lu H., Soria J., Soria C. Oncostatin M induces angiogenesis in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 1999, 19:1835-1842.
31. Wijelath E.S., Carlsen B., Cole T., Chen J., Kothari S., Hammond W.P. Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology. J. Cell Sci. 1997, 110(Pt 7):871-879.
32. Battle T.E., Lynch R.A., Frank D.A. Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis. Cancer Res. 2006, 66:3649-3657.
33. Hiroi M., Mori K., Sakaeda Y., Shimada J., Ohmori Y. STAT1 represses hypoxia-inducible factor-1-mediated transcription. Biochem. Biophys. Res. Commun. 2009, 387:806-810.
34. Platanias L.C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 2005, 5:375-386.
35. Benekli M., Baumann H., Wetzler M. Targeting signal transducer and activator of transcription signaling pathway in leukemias. J. Clin. Oncol. 2009, 27:4422-4432.
36. Niu G., Bowman T., Huang M., Shivers S., Reintgen D., Daud A., Chang A., Kraker A., Jove R., Yu H. Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. Oncogene 2002, 21:7001-7010.
37. Huang M., Page C., Reynolds R.K., Lin J. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells. Gynecol. Oncol. 2000, 79:67-73.
38. Corvinus F.M., Orth C., Moriggl R., Tsareva S.A., Wagner S., Pfitzner E.B., Baus D., Kaufmann R., Huber L.A., Zatloukal K., Beug H., Ohlschlager P., Schutz A., Halbhuber K.J., Friedrich K. Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia 2005, 7:545-555.
39. Azare J., Leslie K., Al-Ahmadie H., Gerald W., Weinreb P.H., Violette S.M., Bromberg J. Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin beta 6. Mol. Cell Biol. 2007, 27:4444-4453.
40. Dechow T.N., Pedranzini L., Leitch A., Leslie K., Gerald W.L., Linkov I., Bromberg J.F. Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C. Proc. Natl. Acad. Sci. USA 2004, 101:10602-10607.
41. Chin Y.E., Kitagawa M., Su W.C., You Z.H., Iwamoto Y., Fu X.Y. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 1996, 272:719-722.
42. Stephanou A., Brar B.K., Knight R.A., Latchman D.S. Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differ. 2000, 7:329-330.
43. Niu G., Wright K.L., Huang M., Song L., Haura E., Turkson J., Zhang S., Wang T., Sinibaldi D., Coppola D., Heller R., Ellis L.M., Karras J., Bromberg J., Pardoll D., Jove R., Yu H. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 2002, 21:2000-2008.
44. Wei D., Le X., Zheng L., Wang L., Frey J.A., Gao A.C., Peng Z., Huang S., Xiong H.Q., Abbruzzese J.L., Xie K. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 2003, 22:319-329.
45. Loeffler S., Fayard B., Weis J., Weissenberger J. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int. J. Cancer 2005, 115:202-213.